Literature DB >> 2368437

Intraoperative and postoperative PTH secretion mode in patients with hyperparathyroidism.

S Fischer1, D Flentje, C Kettelhack, J Schmidt-Gayk, H Buhr, C Herfarth.   

Abstract

The development of a sensitive 2-site immunoradiometric assay which detects only intact human PTH (1-84) enabled us to study kinetics of PTH secretion intraoperatively. In a prospective study, we assessed the PTH (1-84) secretion mode intraoperatively in 54 patients with adenomas, in 14 patients with tertiary hyperparathyroidism (HPT), and in 2 patients with persistent HPT. After the removal of adenomatous or hyperplastic tissue, a significant drop of PTH (1-84) concentration was seen. A 50% decrease in the basal PTH concentration was reached significantly earlier for adenomas than for hyperplasias. In the 2 cases with unrevealing neck exploration, the PTH (1-84) concentrations showed hardly any change. The recovery of PTH secretion was studied in 23 patients, 20 of whom had a single adenoma; in 2 cases, a hyperplasia was present and 1 patient showed the clinical signs of a toxic HPT. We found an initial drop of PTH concentration 4 hours postoperatively below the limit of detection and a rapid recovery within 24 hours postoperatively. The PTH concentration values were well within the normal range after 48-72 hours.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2368437     DOI: 10.1007/bf01658524

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  12 in total

1.  NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS.

Authors:  A L GRABER; R L NEY; W E NICHOLSON; D P ISLAND; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1965-01       Impact factor: 5.958

2.  Intact vs C-terminal/mid-region parathyrin (PTH) assay in diagnosis of hyperparathyroidism--a clinical evaluation.

Authors:  S Y Chu; A K Chu
Journal:  Clin Chem       Date:  1986-12       Impact factor: 8.327

3.  Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy.

Authors:  A G Vagenakis; L E Braverman; F Azizi; G I Portinay; S H Ingbar
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

4.  Urinary cAMP excretion during surgery: an index of successful parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  A M Spiegel; S J Marx; M F Brennan; E M Brown; J O Koehler; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

5.  Recovery of parathyroid hormone secretion after parathyroid adenomectomy.

Authors:  A R Brasier; C A Wang; S R Nussbaum
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

6.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

7.  Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

Authors:  G L Irvin; D J Newell; S D Morgan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

8.  Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1-84) parathyroid hormone.

Authors:  I R Curley; M H Wheeler; J P Aston; R C Brown; I Weeks; J S Woodhead
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

9.  Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay.

Authors:  E Blind; H Schmidt-Gayk; S Scharla; D Flentje; S Fischer; U Göhring; W Hitzler
Journal:  J Clin Endocrinol Metab       Date:  1988-08       Impact factor: 5.958

10.  Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay.

Authors:  E Blind; H Schmidt-Gayk; F P Armbruster; A Stadler
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

View more
  7 in total

1.  Unexpected results using rapid intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.

Authors:  Ignazio Emmolo; Herbert Dal Corso; Giorgio Borretta; Gianluca Visconti; Alessandro Piovesan; Flora Cesario; Felice Borghi
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

2.  Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.

Authors:  Hiroyuki Yamashita; Tom Cantor; Shinya Uchino; Shin Watanabe; Takahiro Ogawa; Taiki Moriyama; Yuji Takamatsu; Masafumi Fukagawa; Shiro Noguchi
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

3.  Suppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism.

Authors:  A Bergenfelz; B Ahrén
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

4.  Parathyroid adenomectomy under local anesthesia with intra-operative monitoring of UcAMP and/or 1-84 PTH.

Authors:  Y Chapuis; P Icard; Y Fulla; L Nonnenmacher; P Bonnichon; A Louvel; B Richard
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

5.  Intraoperative urinary cyclic AMP monitoring in primary hyperparathyroidism.

Authors:  W G Schenk; M Wills; M S MacLeod; J B Hanks
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

6.  Intraoperative monitoring of intact PTH during surgery for primary hyperparathyroidism.

Authors:  A Bergenfelz; A Isaksson; B Ahrén
Journal:  Langenbecks Arch Chir       Date:  1994

7.  A 10-year experience in intraoperative parathyroid hormone measurements for primary hyperparathyroidism: a prospective study of 91 previous unexplored patients.

Authors:  M C Neves; M N Ohe; M Rosano; M Abrahão; O Cervantes; M Lazaretti-Castro; J G H Vieira; I S Kunii; R O Santos
Journal:  J Osteoporos       Date:  2012-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.